4AVAX Technologies. Presents Results of Phase Ⅰ/Ⅱ M-Vax Trial at Annual Meeting of American Association for Cancer Research [ EB/OL]. [2007 - 12 - 18 ]. http://www. avax-tech.com/pressreleases, html.
5ELDER M. Monoclonal antibodies, vaccines, and other immunological cancer treatments: world market[ R]. Kalorama, 2007.5
6TABI Z, MAN S. Challenges for cancer vaccine development[ J]. Adv Drug Deliv Rev, 2006, 58(8) :902 -915.
7Sinkovics J, Horvath J. New development in the virus therapy ofcancer: a historical review[J]. Interviology, 1993,36:193.
